Trial Profile
An Open-Label, Fixed Sequence, Two-Period Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Linvencorvir (Primary) ; Pitavastatin
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Roche
- 01 Feb 2021 Results of Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports from three trials (NCT02952924, NCT03570658 and NCT03717064) published in the Clinical Pharmacology and Therapeutics
- 18 Jan 2021 Results published in the Journal of Clinical Pharmacology
- 21 Mar 2020 Results presented at the 121st Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics